Market Cap : 7.25 B | Enterprise Value : 10.18 B | PE Ratio : 26.29 | PB Ratio : 2.16 |
---|
NAS:SYNH has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:SYNH has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2022-08-11), Syneos Health's share price is $70.4276. Syneos Health's Book Value per Share for the quarter that ended in Jun. 2022 was $32.43. Hence, Syneos Health's PB Ratio of today is 2.17.
Good Sign:
Syneos Health Inc stock PB Ratio (=2.16) is close to 1-year low of 1.98
The historical rank and industry rank for Syneos Health's PB Ratio or its related term are showing as below:
During the past 11 years, Syneos Health's highest PB Ratio was 12.19. The lowest was 1.20. And the median was 2.44.
During the past 12 months, Syneos Health's average Book Value Per Share Growth Rate was 3.60% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 6.00% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 29.80% per year.
During the past 11 years, the highest 3-Year average Book Value Per Share Growth Rate of Syneos Health was 89.90% per year. The lowest was -12.70% per year. And the median was 6.00% per year.
The historical data trend for Syneos Health's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Syneos Health's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Diagnostics & Research industry and Healthcare sector, Syneos Health's PB Ratio distribution charts can be found below:
* The bar in red indicates where Syneos Health's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Syneos Health's PB Ratio for today is calculated as follows:
PB Ratio | = | Share Price | / | Book Value per Share (Q: Jun. 2022) |
= | 70.4276 | / | 32.432 | |
= | 2.17 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
PB Ratio | = | Market Cap | / | (Total Stockholders Equity | - | Preferred Stock) |
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Thank you for viewing the detailed overview of Syneos Health's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Zulueta Alfonso G | director | LILLY CORPORATE CENTER INDIANAPOLIS IN 46285 |
Bodem Barbara W. | director | C/O DENTSPLY SIRONA INC 13320 BALLANTYNE CORPORATE PLACE CHARLOTTE NC 28277 |
Brooks Michael Lee | officer: See remarks | C/O SYNEOS HEALTH, INC. 1030 SYNC STREET MORRISVILLE NC 27560 |
Wilkes David S. | director | ONE BAXTER PARKWAY DEERFIELD IL 60015 |
Connaughton Bernadette | director | C/O VISTERRA, INC. ONE KENDALL SQUARE, #B3301 CAMBRIDGE MA 02139 |
Klitgaard William E | director | 210 CARNEGIE CENTER PRINCETON NJ 08540 |
Meyers Kenneth F | director | 275 NORTH FIELD DRIVE LAKE FOREST IL 60045 |
Monaghan Matthew E. | director | ONE INVACARE WAY ELYRIA OH 44035 |
Harty Linda S | director | MEDTRONIC PLC 710 MEDTRONIC PARKWAY NE, LC-150 MINNEAPOLIS MN 55432 |
Kralowetz Donna Hildebrand | officer: SVP, Chief Accounting Officer | C/O SYNEOS HEALTH, INC. 1030 SYNC STREET MORRISVILLE NC 27560 |
Colvin Paul | officer: Pres., Clinical Solutions | C/O SYNEOS HEALTH, INC. 1030 SYNC STREET MORRISVILLE NC 27560 |
Parks Robert | officer: EVP, Chief Accounting Officer | C/O SYNEOS HEALTH, INC. 1030 SYNC STREET MORRISVILLE NC 27560 |
Olefson Jonathan | officer: General Counsel & Corp Secty | C/O SYNEOS HEALTH, INC. 1030 SYNC STREET MORRISVILLE NC 27560 |
Meggs Jason M. | officer: Chief Financial Officer | C/O SYNEOS HEALTH, INC. 1030 SYNC STREET MORRISVILLE NC 27560 |
Gpe Vii Gp S.a.r.l. | 10 percent owner | CO ADVENT INTERNATIONAL 800 BOYLSTON STREET BOSTON MA 02199 |
From GuruFocus
By Marketwired 06-03-2021
By Marketwired 09-14-2021
Other Sources
By Zacks 2021-10-13
By Zacks 2022-03-28
By Zacks 2022-03-07
By Zacks 2022-02-18
By Zacks 2021-09-10
By Zacks 2021-08-31
By Zacks 2021-08-09
By Zacks 2022-03-23
By Zacks 2021-09-29
By Zacks 2022-03-10
By Zacks 2021-08-10
By Zacks 2022-02-17
By Zacks 2022-02-10